Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany

Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany

AIM: To evaluate 5-year effectiveness and cost between latanoprost or timolol monotherapy in a pilot trial. METHODS: A retrospective, multi-center trial performed at 6 sites in Germany of patients who had a diagnosis of primary open-angle or pigmentary glaucoma, in at least one eye, initiated...

Full description

Bibliographic Details
Main Authors: Jeanette A. Stewart, Lindsay A. Nelson, Michael S. Kristoffersen, Sonja Schölzel, Dietmar Schnober, Ulrich Thelen, William C. Stewart
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2013-04-01
Series:International Journal of Ophthalmology
Subjects:
glaucoma
economic
efficacy
safety
latanoprost
timolol
Germany
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633752/

Internet

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633752/

Similar Items